Overview
Frédéric Chevallier focuses his practice on intellectual property matters, and in particular brings extensive experience leading on cross-border patent patent litigation before the Unified Patent Court (UPC) as well as before French courts. He represents pharmaceutical innovators and high-tech companies in their complex multi-jurisdictional patent disputes including matters involving small molecules, antibodies, Supplementary Protection Certificates (SPCs), medical use claims, and standard essential patents.
He represents clients in infringement and validity proceedings before several central local and regional divisions of the Unified Patent Court, as well as before French courts, in the life sciences and technology, media, and telecommunications (TMT) industries.
His practice also encompasses trademark and copyright litigation, as well as transactional regulatory experience in the life sciences industry.
Results
- Representing a pharmaceutical innovator in the first ever enforcement campaign against several generic manufacturers before the Munich local division of the Unified Patent Court*
- Representing online live gaming companies in revocation and infringement proceedings before the Paris central and Nordic-Baltic regional divisions*
- Representing a pharmaceutical innovator in the first ever cases in France on the enforcement of marketing exclusivity and regulatory data protection against generic manufacturers*
- Successfully represented major international pharmaceutical innovators in the enforcement of Supplementary Protection Certificates (SPCs) leading to the first ever decisions in France and in Europe on the scope and effects of mono-SPCs*
- Successfully represented major international pharmaceutical innovators in the enforcement of patent and SPC rights on small molecules, antibodies, medical use claims, including in preliminary injunction proceedings, both in offensive and defensive disputes*
- Assisting and representing major international pharmaceutical innovators in vaccines related pre-contentious and contentious matters*
- Assisting and representing a major electronic cigarettes manufacturer in its multi-jurisdictional patent dispute against a competitor*
- Representing major players in the field of Standard Essential Patents (SEPs), in offensive and defensive disputes, including in preliminary injunction proceedings*
- Assisting and representing a major oil company in its patent disputes over drilling technology*
- Assisting a client acquiring a gene therapy company*
- Assisting a client in negotiating its distribution agreement for its gene therapy product*
*Matter handled prior to joining McDermott
